ES2129624T3 - Preparacion de proteinas para la prevencion y terapia de periodontitis y otras patologias bacterianas de la cavidad bucal. - Google Patents

Preparacion de proteinas para la prevencion y terapia de periodontitis y otras patologias bacterianas de la cavidad bucal.

Info

Publication number
ES2129624T3
ES2129624T3 ES94903801T ES94903801T ES2129624T3 ES 2129624 T3 ES2129624 T3 ES 2129624T3 ES 94903801 T ES94903801 T ES 94903801T ES 94903801 T ES94903801 T ES 94903801T ES 2129624 T3 ES2129624 T3 ES 2129624T3
Authority
ES
Spain
Prior art keywords
periodontitis
therapy
preparation
proteins
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94903801T
Other languages
English (en)
Inventor
Piera Valenti
Giovanni Antonini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pfizer Italia SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Italia SRL filed Critical Pfizer Italia SRL
Application granted granted Critical
Publication of ES2129624T3 publication Critical patent/ES2129624T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA PREPARACION DE PROTEINA TOPICA A USAR EN LA TERAPIA DE PERIODONTITIS Y ENFERMEDADES DE LOS DIENTES Y DE LOS TEJIDOS DE LA CAVIDAD BUCAL, QUE COMPRENDE UNA MEZCLA DE TRANSFERINA CON AL MENOS UNA PROTEINA ELEGIDA ENTRE ALBUMINAS, LISOZIMAS, INHIBIDORES DE PROTEASA Y SUS MEZCLAS.
ES94903801T 1992-12-17 1993-12-15 Preparacion de proteinas para la prevencion y terapia de periodontitis y otras patologias bacterianas de la cavidad bucal. Expired - Lifetime ES2129624T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920900A IT1256702B (it) 1992-12-17 1992-12-17 Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.

Publications (1)

Publication Number Publication Date
ES2129624T3 true ES2129624T3 (es) 1999-06-16

Family

ID=11401331

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94903801T Expired - Lifetime ES2129624T3 (es) 1992-12-17 1993-12-15 Preparacion de proteinas para la prevencion y terapia de periodontitis y otras patologias bacterianas de la cavidad bucal.

Country Status (13)

Country Link
US (1) US5830489A (es)
EP (1) EP0688226B1 (es)
JP (1) JPH08506098A (es)
AT (1) ATE177646T1 (es)
AU (1) AU690533B2 (es)
CA (1) CA2151909A1 (es)
DE (1) DE69324046T2 (es)
DK (1) DK0688226T3 (es)
ES (1) ES2129624T3 (es)
FI (1) FI952949L (es)
GR (1) GR3030011T3 (es)
IT (1) IT1256702B (es)
WO (1) WO1994013318A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0776163A4 (en) * 1994-09-09 1999-11-24 Univ Maryland BACTERIOPHAGE-ENCODING ENZYMES FOR THE TREATMENT AND PREVENTION OF DENTAL CARIES AND PERIODONTAL DISEASES
JPH08217693A (ja) * 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
US5834424A (en) * 1995-07-12 1998-11-10 Gambit International Limited Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
JP4082782B2 (ja) * 1998-04-30 2008-04-30 雪印乳業株式会社 歯周病予防及び改善剤
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6482396B1 (en) 2001-05-15 2002-11-19 Campina Melkunie B.V. Methods for treating or preventing diseases of the oral cavity
US7087228B2 (en) * 2002-07-03 2006-08-08 University Of Southern California Preventing tooth decay and infective endocarditis using natural oligopeptides
JP4854506B2 (ja) 2003-04-01 2012-01-18 ユニバーシティ オブ サザン カリフォルニア 疾患のリスクを予測および評価するためのう食リスク試験
AU2004238285A1 (en) * 2003-05-07 2004-11-25 Dmi Biosciences, Inc Oral care methods and products
US20050019317A1 (en) * 2003-07-22 2005-01-27 Cheng Bridget Qiuying Composition for human immunostimulation containing Lysozyme and Lactal Bumin
US9127045B2 (en) * 2005-11-17 2015-09-08 University Of Southern California Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides
US20110206749A1 (en) * 2010-02-19 2011-08-25 J.M. Huber Corporation Silica materials for reducing oral malador
CN107115565B (zh) * 2017-06-28 2020-10-16 陕西师范大学 一种羟基磷灰石/相转变溶菌酶涂层杂化材料及其制备方法
CN108251482B (zh) * 2018-02-28 2021-01-22 安徽精准医疗产业研究院有限公司 三酶一酵鸡胚肽的生产方法
KR102441460B1 (ko) * 2020-04-01 2022-09-06 김종길 치주 질환 예방 및 개선을 위한 반려동물용 영양제 조성물 및 그로부터 제조되는 영양제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651433B1 (fr) * 1989-09-07 1994-01-14 Dominique Dana Complexe enzymatique a activite sur le tartre et la carie dentaire.
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
US5422108A (en) * 1991-09-19 1995-06-06 Smart Plants International Inc. Protection of plants against plant pathogens

Also Published As

Publication number Publication date
ITRM920900A0 (it) 1992-12-17
ATE177646T1 (de) 1999-04-15
ITRM920900A1 (it) 1994-06-17
US5830489A (en) 1998-11-03
AU5812394A (en) 1994-07-04
FI952949A0 (fi) 1995-06-15
AU690533B2 (en) 1998-04-30
EP0688226B1 (en) 1999-03-17
DE69324046T2 (de) 1999-10-21
IT1256702B (it) 1995-12-12
FI952949A7 (fi) 1995-06-15
GR3030011T3 (en) 1999-07-30
CA2151909A1 (en) 1994-06-23
WO1994013318A1 (en) 1994-06-23
DE69324046D1 (de) 1999-04-22
DK0688226T3 (da) 1999-10-11
JPH08506098A (ja) 1996-07-02
FI952949L (fi) 1995-06-15
EP0688226A1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
ECSP10004352A (es) Composición farmacéutica líquida
ES2136662T3 (es) Formas de presentacion farmaceuticas y de otro tipo.
ES2169258T3 (es) Utilizacion de proteasa de subtilisina mutada en productos cosmeticos.
DK0825847T3 (da) Tandrensningspræparater
HUP0301842A2 (hu) Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
ES2173284T3 (es) Agentes endoparasicitidas.
ES2174248T3 (es) Composiciones para la eliminacion de una placa dental.
ES2036553T3 (es) Composiciones farmaceuticas que tienen actividad antineoplastica.
PE34796A1 (es) Composicion oral que comprende un nuevo tripeptido
ES2170918T3 (es) Inhibidor de proteina quinasa c sustituidos con halo.
BR9808875A (pt) Combinação de analgésicos
ES2168285T3 (es) Agentes endoparasiticidas que contienen praziquantel y epsiprantel.
GR3030011T3 (en) Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity
ES2181710T3 (es) Adenovirus recombinantes y su utilizacion en terapia genica para el tratamiento de las patologias oculares.
ATE284201T1 (de) Fluoridfreie zahnremineralisierung
ES2151517T3 (es) Efectos de filamentos de actina sobre la estructura y lisis de coagulos de fibrina.
ATE197250T1 (de) Morphogeninduzierte regenerierung der dentin
ES2187489T3 (es) Composiciones farmaceuticas a base de diclofenac.
AR009819A1 (es) Inhibidores de la proteasa proteinicos estabilizados y sus variantes
ES2149969T3 (es) Composicion antitusiva que contiene un antitusivo y benzidamina.
ES2170971T3 (es) Uso de oligosacaridos para el refuerzo del poder edulcorante y para el mejoramiento del sabor de una mezcla de acesulfamo-k y aspartamo.
CU22820A3 (es) Mezcla de aminoácidos y su uso contra la micosis
AU3739500A (en) Protease resistant flint analogs

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 688226

Country of ref document: ES